Skip to main content

Gefapixant

ADVERTISEMENT
Identification
Molecular formula
C23H36N2O
CAS number
1219908-06-9
IUPAC name
4-[2-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)-1-methyl-ethyl]morpholine
State
State
Gefapixant is typically a solid at room temperature, appearing as a white crystalline powder.
Melting point (Celsius)
105.80
Melting point (Kelvin)
378.95
Boiling point (Celsius)
392.40
Boiling point (Kelvin)
665.55
General information
Molecular weight
397.57g/mol
Molar mass
397.5650g/mol
Density
1.2300g/cm3
Appearence

Gefapixant is typically found as a white to off-white crystalline powder.

Comment on solubility

Solubility of 4-[2-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)-1-methyl-ethyl]morpholine

The solubility of the compound 4-[2-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)-1-methyl-ethyl]morpholine can be quite complex due to its unique structural characteristics. This particular compound is a morpholine derivative, which generally influences its solubility in several ways:

  • Polarity: The presence of morpholine contributes to a certain degree of polarity in the molecule. This can enhance its solubility in polar solvents.
  • Hydrophobic and Hydrophilic Balance: The benzyl group and bicyclic structure introduce hydrophobic characteristics, potentially making the compound less soluble in water but more soluble in organic solvents.
  • Temperature Dependence: Like many organic compounds, solubility may increase with temperature. Higher temperatures can disrupt intermolecular interactions, leading to better solvation.

In terms of practical applications and interactions in various environments, understanding its solubility is crucial. It can dictate the behavior of the compound in biological systems, in drug formulation, and in various chemical processes. Therefore, it is essential to conduct solubility studies under specific conditions to determine its behavior accurately.

To summarize, while it is challenging to predict exact solubility values without empirical data, the structural attributes of this compound strongly suggest that:

  • It may exhibit moderate solubility in polar organic solvents.
  • It could be less soluble in warm or cold water due to its hydrophobic characteristics.
  • Further analysis is necessary to confirm solubility trends based on the intended application.
Interesting facts

Exploring 4-[2-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)-1-methyl-ethyl]morpholine

The compound 4-[2-(3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl)-1-methyl-ethyl]morpholine is a fascinating example of a complex organic molecule that exhibits significant potential in medicinal chemistry. Here are some intriguing insights about this compound:

  • Structural Uniqueness: The compound contains a morpholine ring, a six-membered ring known for its diverse biological activity. Its presence in pharmaceutical compounds often enhances solubility and modulates pharmacological properties.
  • Diverse Applications: Variations of morpholine derivatives are commonly explored as intermediates for drug development, owing to their ability to modulate drug action and improve bioavailability.
  • Complex Architecture: The incorporation of the 3-benzyl-3,9-diazabicyclo[3.3.1]nonan-9-yl group adds a layer of complexity, potentially influencing the compound’s interactions with biological targets. The bicyclic structure is known for its stiffness, which may contribute to its biological efficacy.
  • Potential Biological Activities: Molecules of this type are often investigated for activities such as antitumor, antiviral, and antidepressant effects, making them of great interest in the pharmaceutical industry.
  • Research Interests: Ongoing research efforts focused on the pharmacodynamics and pharmacokinetics of similar compounds may unveil numerous therapeutic possibilities and enhance the understanding of their mechanisms of action.

As a chemistry student or scientist delving into the world of organic compounds, this particular compound serves as a reminder of the intricate relationships between structure and function in drug design. Its study not only furthers our understanding of chemical interactions but also inspires new avenues for therapeutic innovation.